Singapore vs Sweden: Proportion of isolates with decreased susceptibility or resistance
Singapore
1.5
in 2018
Sweden
1.5
in 2018
Singapore rank
14th
Sweden rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Singapore
- Sweden
How they compare
Singapore currently reports 1.5 against 1.5 in Sweden, a difference of 0.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Sweden ahead.
Singapore ranks 14th and Sweden ranks 14th of 51 countries.
Across the 2 decades both report, Singapore averaged higher in 1 and Sweden in 1.
Head to head by decade
| Decade | Singapore | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.25 | 2.78 | 1.53 | Sweden |
| 2010s | 2.43 | 2.03 | 0.4028 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Singapore or Sweden?
- Singapore, at 1.5 against 1.5 in Sweden as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Singapore and Sweden?
- 0, with Singapore ahead.
- How many years of comparable data are there for Singapore and Sweden?
- 10 years are reported by both, from 2009 to 2018.
- How do Singapore and Sweden rank globally for proportion of isolates with decreased susceptibility or resistance?
- Singapore ranks 14th and Sweden ranks 14th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.